How to Evaluate Patients and Educate Them About Self-Examinations for Tardive Dyskinesia Between Appointments

The Journal of
Clinical Psychiatry

Tardive Dyskinesia

Patients taking dopamine-blocking agents such as antipsychotics are at risk for developing tardive dyskinesia. In this webcast, Drs McEvoy and Nierenberg discuss symptoms of tardive dyskinesia, how to observe patients (whether in person or via telemedicine), and how to educate patients and families about TD.

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

J Clin Psychiatry. 2021;82(1):NU19047WC6C.

To cite: McEvoy JP, Nierenberg AA. How to evaluate patients and educate them about self-examinations for tardive dyskinesia between appointments. J Clin Psychiatry. 2021;82(1):NU19047WC6C.
To share: https://doi.org/10.4088/JCP.NU19047WC6C

From the Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University (Dr McEvoy); and Dauten Family Center for Bipolar Treatment Innovation and the Depression Clinical and Research Program, Massachusetts General Hospital, and Department of Psychiatry, Harvard Medical School, Boston (Dr Nierenberg).